Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
10.25
1.31
12.78%
Share Warrants & Outstandings
Total Reserve
31.16
63.40
-32.24
-50.85%
Shareholder's Funds
42.72
73.66
-30.94
-42.00%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
19.40
-18.47
-95.21%
Secured Loans
0.00
10.68
-10.68
-100.00%
Unsecured Loans
0.93
8.73
-7.80
-89.35%
Deferred Tax Assets / Liabilities
-0.03
11.35
-11.38
-100.26%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.52
-1.52
-100.00%
Total Non-Current Liabilities
0.95
32.27
-31.32
-97.06%
Current Liabilities
Trade Payables
1.25
8.58
-7.33
-85.43%
Other Current Liabilities
3.27
3.35
-0.08
-2.39%
Short Term Borrowings
0.11
49.24
-49.13
-99.78%
Short Term Provisions
0.00
1.11
-1.11
-100.00%
Total Current Liabilities
4.63
62.28
-57.65
-92.57%
Total Liabilities
48.30
168.21
-119.91
-71.29%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
109.10
-100.74
-92.34%
Less: Accumulated Depreciation
2.39
47.13
-44.74
-94.93%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
61.97
-56.01
-90.38%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.09
-0.09
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
1.70
6.69
393.53%
Other Non Current Assets
0.00
0.94
-0.94
-100.00%
Total Non-Current Assets
15.03
96.82
-81.79
-84.48%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
12.90
16.74
-3.84
-22.94%
Sundry Debtors
9.47
48.50
-39.03
-80.47%
Cash and Bank
3.42
3.08
0.34
11.04%
Other Current Assets
1.77
1.19
0.58
48.74%
Short Term Loans and Advances
5.72
1.88
3.84
204.26%
Total Current Assets
33.28
71.39
-38.11
-53.38%
Net Current Assets (Including Current Investments)
28.65
9.11
19.54
214.49%
Total Current Assets Excluding Current Investments
33.28
71.39
-38.11
-53.38%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
168.21
-119.91
-71.29%
Contingent Liabilities
0.00
1.95
-1.95
-100.00%
Total Debt
1.04
68.64
-67.60
-98.48%
Book Value per share (adjusted)
36.14
55.51
-19.37
-34.89%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024






